申请人:Wang Zhaoyin
公开号:US20140243303A1
公开(公告)日:2014-08-28
The present invention relates to spirocyclic compounds of formula I, namely spirocyclic (1H-pyrazol-4-yl)-3-(1-(2,6-dichloro-3-fiuorophenyl)ethoxy)pyridin-2-amines having protein kinase inhibitory activity, and methods of synthesizing and using such compounds. Preferred compounds are c-Met and/or ALK inhibitors useful for the treatment of abnormal cell growth, such as cancers.
R
2
is selected from
本发明涉及公式I的螺环化合物,即螺环(1H-吡唑-4-基)-3-(1-(2,6-二氯-3-氟苯基)乙氧基)吡啶-2-胺,具有蛋白激酶抑制活性,以及制备和使用这种化合物的方法。首选化合物是c-Met和/或ALK抑制剂,可用于治疗异常细胞生长,如癌症。R2从中选择。